Polymorphisms in IL-10 and TGF-β gene promoter are associated with lower risk to gastric cancer in a Mexican population

[1]  X. Hua,et al.  Alcohol consumption and risk of gastric cardia adenocarcinoma and gastric noncardia adenocarcinoma: A 16‐year prospective analysis from the NIH‐AARP diet and health cohort , 2018, International journal of cancer.

[2]  Y. Nishino,et al.  Associations of cigarette smoking and alcohol drinking with stomach cancer survival: A prospective patient cohort study in Japan , 2018, International journal of cancer.

[3]  A. S. Ramakrishnan,et al.  TGFβ C-509T, TGFβ T869C, XRCC1 Arg194Trp, IKBα C642T, IL4 C-590T Genetic polymorphisms combined with socio-economic, lifestyle, diet factors and gastric cancer risk: A case control study in South Indian population. , 2018, Cancer epidemiology.

[4]  Zhen-ning Wang,et al.  Association between alcohol consumption and the risk of gastric cancer: a meta-analysis of prospective cohort studies , 2017, Oncotarget.

[5]  Hai-Hua Shu,et al.  Alcohol consumption and gastric cancer risk: a meta-analysis of prospective cohort studies , 2017, Oncotarget.

[6]  C. Maldonado-Bernal,et al.  Circulating blood levels of IL-6, IFN-γ, and IL-10 as potential diagnostic biomarkers in gastric cancer: a controlled study , 2017, BMC Cancer.

[7]  R. DiPaolo,et al.  Regulation of Gastric Carcinogenesis by Inflammatory Cytokines , 2017, Cellular and molecular gastroenterology and hepatology.

[8]  J. Torres,et al.  Polymorphisms in HLA‐DQ genes, together with age, sex, and Helicobacter pylori infection, as potential biomarkers for the early diagnosis of gastric cancer , 2017, Helicobacter.

[9]  X. Xia,et al.  Alcohol Consumption and Gastric Cancer Risk: A Meta-Analysis , 2017, Medical science monitor : international medical journal of experimental and clinical research.

[10]  A. Burguete-García,et al.  Risk allelic load in Th2 and Th3 cytokines genes as biomarker of susceptibility to HPV-16 positive cervical cancer: a case control study , 2016, BMC Cancer.

[11]  Huan Wang,et al.  TGF-β1 C-509T and T869C polymorphisms and cancer risk: a meta analysis. , 2015, International journal of clinical and experimental medicine.

[12]  C. Mathers,et al.  Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 , 2015, International journal of cancer.

[13]  F. Bazzoli,et al.  Epidemiology of Helicobacter pylori Infection , 2014, Helicobacter.

[14]  I. Fabregat,et al.  TGF-beta signaling in cancer treatment. , 2014, Current pharmaceutical design.

[15]  M. Loh,et al.  Interleukin-4 and -8 gene polymorphisms and risk of gastric cancer in a population in Southwestern China. , 2014, Asian Pacific journal of cancer prevention : APJCP.

[16]  C. Maldonado-Bernal,et al.  Toll‐Like Receptors and Cytokines are Upregulated during Helicobacter pylori Infection in Children , 2013, Helicobacter.

[17]  Zhibin Yu,et al.  The interleukin 10 -819C/T polymorphism and cancer risk: a HuGE review and meta-analysis of 73 studies including 15,942 cases and 22,336 controls. , 2013, Omics : a journal of integrative biology.

[18]  Lili Ma,et al.  Transforming Growth Factor-β1 and -β2 in Gastric Precancer and Cancer and Roles in Tumor-Cell Interactions with Peripheral Blood Mononuclear Cells In Vitro , 2013, PloS one.

[19]  R. Radišauskas,et al.  Alcohol consumption and risk of gastric cancer: a cohort study of men in Kaunas, Lithuania, with up to 30 years follow-up , 2012, BMC Cancer.

[20]  Gang Huang,et al.  Interleukin-10-819 promoter polymorphism in association with gastric cancer risk , 2012, BMC Cancer.

[21]  Z. Dong,et al.  Polymorphisms of transforming growth factor‐β1 associated with increased risk of gastric cardia adenocarcinoma in north China , 2011, International journal of immunogenetics.

[22]  B. Song,et al.  Polymorphisms of interleukin-10 promoter are not associated with prognosis of advanced gastric cancer. , 2011, World journal of gastroenterology.

[23]  Jun Yu,et al.  Association between the TGFB1 -509C/T and TGFBR2 -875A/G polymorphisms and gastric cancer: a case-control study. , 2011, Oncology letters.

[24]  F. Bazzoli,et al.  Gastric cancer, Helicobacter pylori infection and other risk factors. , 2010, World journal of gastrointestinal oncology.

[25]  M. Camorlinga,et al.  Polymorphisms in TNF and HSP‐70 show a significant association with gastric cancer and duodenal ulcer , 2010, International journal of cancer.

[26]  Y. Liu,et al.  TGF-beta promotes invasion and metastasis of gastric cancer cells by increasing fascin1 expression via ERK and JNK signal pathways. , 2009, Acta biochimica et biophysica Sinica.

[27]  S. Tatebe,et al.  Serum interleukin-6 and -10 levels in patients with gastric cancer , 2009, Gastric Cancer.

[28]  L. Castellano,et al.  Immunological and Genetic Evidence for a Crucial Role of IL-10 in Cutaneous Lesions in Humans Infected with Leishmania braziliensis1 , 2008, The Journal of Immunology.

[29]  B. Cao,et al.  Correlation of transforming growth factor beta‐1 gene polymorphisms C‐509T and T869C and the risk of gastric cancer in China , 2008, Journal of gastroenterology and hepatology.

[30]  Richard A Flavell,et al.  ‘Yin–Yang’ functions of transforming growth factor‐β and T regulatory cells in immune regulation , 2007, Immunological reviews.

[31]  H. Sugimura,et al.  Effects of interleukin‐10 gene polymorphism on the development of gastric cancer and peptic ulcer in Japanese subjects , 2007, Journal of gastroenterology and hepatology.

[32]  Jian-ming Wang,et al.  Variant alleles of TGFB1 and TGFBR2 are associated with a decreased risk of gastric cancer in a Chinese population , 2007, International journal of cancer.

[33]  M. Plummer,et al.  Genetic polymorphisms in anti-inflammatory cytokine signaling and the prevalence of gastric precancerous lesions in Venezuela , 2006, Cancer Causes & Control.

[34]  Christopher F. Martin,et al.  Gastric cancer and the high combination prevalence of host cytokine genotypes and Helicobacter pylori in Honduras. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[35]  C. Hurley,et al.  A molecular mechanism for the differential regulation of TGF-β1 expression due to the common SNP −509C-T (c. −1347C > T) , 2006, Human Genetics.

[36]  S. Tsujitani,et al.  Interleukin‐10 expression significantly correlates with minor CD8+ T‐cell infiltration and high microvessel density in patients with gastric cancer , 2006, International journal of cancer.

[37]  S. Kikuchi,et al.  Serum levels of transforming growth factor β1 are significantly correlated with venous invasion in patients with gastric cancer † , 2006, Journal of gastroenterology and hepatology.

[38]  R. R. Henry,et al.  Gastric cancer risk in a Mexican population: Role of Helicobacter pylori CagA positive infection and polymorphisms in interleukin‐1 and ‐10 genes , 2006, International journal of cancer.

[39]  E. El-Omar,et al.  Role of the polymorphic IL‐1B, IL‐1RN and TNF‐A genes in distal gastric cancer in Mexico , 2005, International journal of cancer.

[40]  J. Steinke,et al.  Functional Analysis of −571 IL-10 Promoter Polymorphism Reveals a Repressor Element Controlled by Sp11 , 2004, The Journal of Immunology.

[41]  H. Brenner,et al.  Epidemiology of Helicobacter pylori Infection , 2004, Helicobacter.

[42]  C. Prinz,et al.  Cytokine gene polymorphisms influence mucosal cytokine expression, gastric inflammation, and host specific colonisation during Helicobacter pylori infection , 2004, Gut.

[43]  J. Massagué,et al.  Cytostatic and apoptotic actions of TGF-β in homeostasis and cancer , 2003, Nature Reviews Cancer.

[44]  Chien-Jen Chen,et al.  Interleukin‐10 genotypes associate with the risk of gastric carcinoma in Taiwanese Chinese , 2003, International journal of cancer.

[45]  A. Helicobacter,et al.  Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts , 2001, Gut.

[46]  G. Catalano,et al.  Serum interleukin‐10 levels in patients with advanced gastrointestinal malignancies , 1999, Cancer.

[47]  D. Purdie,et al.  Interleukin‐10 promoter polymorphism predicts initial response of chronic hepatitis C to interferon alfa , 1999, Hepatology.

[48]  P. Woo,et al.  Polymorphic haplotypes of the interleukin-10 5' flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis. , 1999, Arthritis and rheumatism.

[49]  G. Perez-Perez,et al.  Validation of a Serologic Test for the Diagnosis of Helicobacter pylori Infection and the Immune Response to Urease and CagA in Children , 1998, American Journal of Gastroenterology.

[50]  P. Barnes,et al.  Haplotype associated with low interleukin-10 production in patients with severe asthma , 1998, The Lancet.

[51]  F. Sitas.  IARC Working Group on the Evaluation of Carcinogenic Risks to Humans (incl Sitas F.) IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. A Review of Human Carcinogens , 2011 .

[52]  J. Bai,et al.  Elevated serum level and gene polymorphisms of TGF‐β1 in gastric cancer , 2008, Journal of clinical laboratory analysis.

[53]  Schistosomes, liver flukes and Helicobacter pylori. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 7-14 June 1994. , 1994, IARC monographs on the evaluation of carcinogenic risks to humans.